NewsRx

Search our medical news database

Sports Medicine

Performance of NFL wide receivers, running backs post-ACL injury falls by one third

Published in Physician Law Weekly, December 20th, 2006

The good news for NFL players who sustain an injury to their anterior cruciate ligament (ACL) is that they'll likely play again in the NFL. The bad news is, at least one third of them will return with diminished performance on the field, concludes a study in a recent issue of The American Journal of Sports Medicine.

"Although there have been over 2000 articles on the ACL in the past 20 years, only a few have focused on the pro player," writes author James L. Carey, MD (Dr. Carey is now affiliated with Vanderbilt Sports Medicine, Nashville, Tenn.) and colleagues from the Department of Orthopaedic Surgery, University of Pennsylvania School of Medicine,...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Physician Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook